Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fujifilm Integrates Structured Reporting into Digital Pathology Workflow

By LabMedica International staff writers
Posted on 26 May 2026

FUJIFILM Healthcare Americas Corporation (Lexington, MA, USA) and mTuitive (Centerville, MA, USA) have formed a strategic partnership to integrate mTuitive’s structured pathology reporting platform with Fujifilm’s Synapse Pathology. More...

A comprehensive pathology PACS, Synapse Pathology streamlines case management through proprietary advances in image digitization. By connecting structured pathology reporting with digital pathology workflows, the collaboration aims to unify diagnostic data across pathology and imaging, accelerate decision-making, and support coordinated, evidence-based patient care.

The integrated workflow establishes a pathology-to-enterprise pipeline in which structured pathology reports—including CAP and Commission on Cancer-compliant synoptic data and biomarker information—automatically flow from mTuitive through the Laboratory Information System (LIS) into Synapse. By addressing the common problem of interdepartmental data silos, the approach is intended to enable real-time collaboration among radiologists, oncologists, and pathologists. The solution respects the LIS as the system of record while synchronizing finalized content to the enterprise imaging environment.

Key operational advantages include the automatic availability of final pathology reports in Synapse after sign-out, helping ensure that care teams are working from the same structured information. During tumor boards, these reports can be viewed alongside radiology images to support more cohesive decision-making. The integration is also designed to reduce duplicative data entry and help organizations gain more value from existing systems without adding new platforms. In addition, the resulting structured data can support cancer registries, clinical analytics, research, and artificial intelligence applications.

“By integrating mTuitive's structured reporting capabilities with Synapse's Pathology, our robust, open-cloud accessible platform, we're empowering healthcare teams with the unified diagnostic insights they need to deliver faster, more coordinated patient care,” said Dr. Mark Lloyd, Vice President of Digital Pathology, FUJIFILM Healthcare Americas Corporation.

“As we deepen our alliance with Fujifilm, we are intentionally building an ecosystem where imaging, pathology, and informatics work in concert to give care teams faster, more confident answers for their patients,” stated Hans Wernke, Vice President of Strategic Alliances at mTuitive.
 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: FDA approval enables the OncoMate MSI Dx Analysis System to identify patients who may benefit from Merck’s KEYTRUDA anti-PD-1 therapy. (Photo courtesy of Promega)

Microsatellite Instability Test Gains FDA Approval for Immunotherapy Selection

Microsatellite instability-high (MSI-H) status is a key tumor biomarker used to guide treatment decisions in precision oncology. Testing can identify adult and pediatric patients with unresectable or metastatic... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.